SS Pharmaceutical to Launch 'Cialis®', Japan's First Non-Prescription ED Treatment, on July 31st
Key facts
- SS Pharmaceutical to Launch 'Cialis®', Japan's First Non-Prescription ED Treatment, on July 31st
- SS Pharmaceutical will launch 'Cialis®', Japan's first switch-OTC ED medication, on July 31, 2026. Given findings that approximately one in two Japanese men may experience ED, the company aims to create an environment where treatment can be accessed with pharmacist guidance.
- Source: PR Times
- Date: June 10, 2026
Direct answer
SS Pharmaceutical will launch 'Cialis®', Japan's first switch-OTC ED medication, on July 31, 2026. Given findings that approximately one in two Japanese men may experience ED, the company aims to create an environment where treatment can be accessed with pharmacist guidance.
- Citation
- SS Pharmaceutical to Launch 'Cialis®', Japan's First Non-Prescription ED Treatment, on July 31st (June 10, 2026), PR Times
- Source
- PR Times
- Date
- June 10, 2026
SS Pharmaceutical will launch 'Cialis®', Japan's first switch-OTC ED medication, on July 31, 2026. Given findings that approximately one in two Japanese men may experience ED, the company aims to create an environment where treatment can be accessed with pharmacist guidance.
📋 Article Processing Timeline
- 📰 Published: June 10, 2026 at 11:00
- 🔍 Collected: June 10, 2026 at 11:32 (32 min after Published)
- 🤖 AI Analyzed: June 11, 2026 at 01:28 (13h 55m after Collected)
Background
ED is a condition that can affect anyone. Large-scale surveys by SS Pharmaceutical indicate that approximately one in two Japanese men may experience ED. However, lack of awareness and failure to seek help remain significant issues, compounded by misconceptions about the treatment. The company aims to destigmatize ED as a manageable health condition.
Product Overview
While Cialis® has been available as a prescription medication in over 100 countries for over 20 years, it will now be provided for the first time as a switch-OTC medication, allowing purchase with proper information provided by a pharmacist.
Key Features
1. Effects start within 30 minutes.
2. Effects last up to 36 hours.
3. Less affected by meals and alcohol.
Suggested Retail Price: 5,808 yen (including tax)
Active Ingredient: Tadalafil 10mg
Launch Date: July 31, 2026 (pre-sale); August 31, 2026 (nationwide).
FAQ
When will SS Pharmaceutical release Cialis® as a non-prescription ED treatment in Japan?
SS Pharmaceutical will launch Cialis® as Japan's first switch-OTC ED medication on July 31, 2026.
What percentage of Japanese men may experience ED according to the findings mentioned in the article?
Approximately one in two Japanese men may experience ED, as indicated in the article.
How does SS Pharmaceutical plan to facilitate access to Cialis® after its OTC launch?
SS Pharmaceutical aims to create an environment where Cialis® can be accessed with pharmacist guidance.
What is the significance of the July 31, 2026 launch date for Cialis® in Japan?
The July 31, 2026 launch marks the introduction of Japan's first non-prescription ED treatment, Cialis®.
Which pharmaceutical company is responsible for launching Cialis® as an OTC ED medication in Japan?
SS Pharmaceutical is the company launching Cialis® as Japan's first switch-OTC ED medication in 2026.